Clinical trial

SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer

NCT07662395

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-05-09

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2026-05-09Date precision: day

Registry last updated2026-06-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Double Blindunresolved

Interventions

TislelizumabDRUG · verified · RxNorm: tislelizumab

PaclitaxelDRUG · verified · RxNorm: paclitaxel

Nab-paclitaxelDRUG

CarboplatinDRUG · verified · RxNorm: carboplatin

CisplatinDRUG · verified · RxNorm: cisplatin

PemetrexedDRUG · verified · RxNorm: pemetrexed

Sponsors & collaborators

Sinocelltech Ltd.lead sponsor

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07662395 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.